Analysts Divided on 3M as Fair Value Rises Amid New Initiatives and Persistent Risks

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

20 Aug 24

Updated

10 Dec 25

Views

463

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

28.0%

7D

1.1%

Loading

1Y

28.0%

7D

1.1%

You can edit this narrative until Dec 11 3:10 AM. Then, changes will post as Updates.

Author's Valuation

US$174.254.9% undervalued

AnalystConsensusTarget Fair Value

Shared on 10 Dec 25

Fair value Decreased 0.39%

MMM: Turnaround Progress Will Face Ongoing PFAS Litigation And Portfolio Reshaping Risks

Our fair value estimate for 3M has been trimmed slightly to $174.25 from $174.94 as analysts balance higher price targets and improving expectations for new product driven growth and management's turnaround progress against persistent PFAS litigation risk. Analyst Commentary Street research remains divided on 3M, with recent notes highlighting improving execution and product driven growth, offset by continued concern around PFAS liabilities and mixed end market demand.

Shared on 26 Nov 25

Fair value Increased 0.36%

MMM: Shares Will Balance Turnaround Progress With Litigation and Asset Sale Uncertainty

Analysts have marginally raised their fair value estimate for 3M to $174.94, citing improved organic growth, ongoing new product introductions, and increased profit margin expectations following recent quarterly results. Analyst Commentary Recent analyst research has revealed a shifting perspective on 3M, as several experts adjust their outlooks based on the company’s latest earnings performance and ongoing strategic initiatives.

Shared on 06 Nov 25

Fair value Increased 3.87%

MMM: Shares Will Balance Turnaround Progress With Ongoing Litigation and Portfolio Changes

Analysts have raised their fair value estimate for 3M to $174.31 from $167.81. This change reflects improved organic growth prospects and progress on turnaround initiatives highlighted in recent research updates.

Shared on 22 Oct 25

Fair value Increased 3.07%

3M's fair value estimate has increased by $5.00 to $167.81 as analysts cite modest operating outperformance and positive momentum from new product initiatives, despite some lingering concerns. Analyst Commentary Recent updates from Street research highlight diverging analyst sentiment regarding 3M's valuation trajectory and execution on strategic initiatives.

Shared on 08 Oct 25

Fair value Increased 0.73%

Narrative Update: 3M Analyst Price Target Revision Analysts have increased their price target for 3M to $162.81 from $161.63, citing improved full-year guidance prospects and renewed interest as a short-term buy idea. Analyst Commentary Recent commentary from Street research highlights both optimistic and cautious stances regarding 3M’s near-term prospects.

Shared on 07 May 25

Fair value Increased 8.80%

Shared on 30 Apr 25

Fair value Decreased 0.54%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 23 Apr 25

Fair value Decreased 2.63%

AnalystConsensusTarget has increased revenue growth from 1.5% to 1.7%.

Shared on 16 Apr 25

Fair value Increased 1.97%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Decreased 3.51%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 1.06%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

Fair value Increased 0.039%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Increased 2.16%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 10 Mar 25

Fair value Decreased 6.12%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget Fair Value

US$174.25

4.9% undervalued

Future estimation in

Growth p.a.

Growth p.a.

%

Decrease

Increase

Current revenue growth rate

2.32%

Industrials revenue growth rate

0.18%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

7.67%

Calculation

US$5.14b

Earnings '28

x

21.01x

PE Ratio '28

=

US$108.09b

Market Cap '28

US$108.09b

Market Cap '28

/

497.68m

No. shares '28

=

US$217.18

Share Price '28

US$217.18 Share Price '28

Discounted to 2025 @ 7.67% p.a.

=

US$174.01

Fair Value '25